VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2020 | Therapeutic landscape for cluster headache

Stewart Tepper • 24 May 2020
EAN 2020
Headache Antibodies Ergotamine Galcanezumab Lithium Sumatriptan Verapamil Zolmitriptan
Prevention Treatment

Stewart Tepper, MD, Professor of Neurology, Geisel School of Medicine at Dartmouth, Hanover, NH, discusses the current treatment options for cluster headaches. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Stewart Tepper

2:05
AHS highlights: atogepant and zavegepant for migraine treatment
Stewart Tepper • 17 Jun 2022
20:54
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic
Stewart Tepper • 24 May 2020
5:55
Increased placebo response over time in migraine preventive trials
Stewart Tepper • 17 Jun 2022
2:00
Discontinuation of anti-CGRP antibodies in non-responders
Stewart Tepper • 17 Jun 2022

Related Videos

2:58
Exploring the link between migraine and psychiatric comorbidities
Claudia Altamura • 2 Jul 2023
2:01
Targeting CGRP: Is it better to target the ligand or receptor in migraine prevention?
Claudia Altamura • 2 Jul 2023
0:53
Factors influencing genetic testing for hemiplegic migraine
Irene de Boer • 1 Jul 2023
1:18
The potential of combination therapy in migraine
Alan Rapoport • 1 Jul 2023
The content of VJNeurology is intended for healthcare professionals